Rethinking rare disease: longevity-enhancing drug targets through X-linked aneuploidy.
Trends Genet. 2022 Apr;38(4):317-320. doi: 10.1016/j.tig.2021.10.006. Epub 2021 Oct 23.
Trends Genet. 2022.
PMID: 34702579